Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
33 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsInnovent Receives IND Approval to Initiate Clinical Trials in China with Sintilimab in Combination with ...
(WorldNews China)

 
 

15 october 2018 07:14:25

 
Innovent Receives IND Approval to Initiate Clinical Trials in China with Sintilimab in Combination with ...
(WorldNews China)
 


SUZHOU, China, Oct. 14, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today announced that its IND application for a combination therapy of IBI308 (Sintilimab, an anti-PD-1 monoclonal antibody) and IBI305 (a biosimilar to the recombinant humanized anti-VEGF monoclonal antibody bevacizumab), has been approved by the National Medical Products Administration (NMPA, formerly known as CFDA) for clinical development. Innovent will initiate clinical trials based on this combination to assess its safety and efficacy in patients with Non-Small Cell Lung Cancer (NSCLC) and...


 
16 viewsCategory: General > Asia > China
 
Powering China`s air express upstream
(WorldNews China)
Kenya must face up to rising claims of racial discrimination by Chinese against locals
(WorldNews China)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten